Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO

Bin Yang, Alexander W. Hird, Daniel John Russell, Benjamin P. Fauber, Les A. Dakin, Xiaolan Zheng, Qibin Su, Robert Godin, Patrick Brassil, Erik Devereaux, James W. Janetka

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Cell-based subset screening of compounds using a Gli transcription factor reporter cell assay and shh stimulated cell differentiation assay identified a series of bisamide compounds as hedgehog pathway inhibitors with good potency. Using a ligand-based optimization strategy, heteroaryl groups were utilized as conformationally restricted amide isosteres replacing one of the amides which significantly increased their potency against SMO and the hedgehog pathway while decreasing activity against p38α kinase. We report herein the identification of advanced lead compounds such as imidazole 11c and 11f encompassing good p38α selectivity, low nanomolar potency in both cell assays, excellent physiochemical properties and in vivo pharmacokinetics.

Original languageEnglish
Pages (from-to)4907-4911
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume22
Issue number14
DOIs
StatePublished - Jul 15 2012
Externally publishedYes

Keywords

  • Amide isosteres
  • Hedgehog pathway
  • Heterocycles
  • Patched
  • Smoothened
  • p38

Fingerprint Dive into the research topics of 'Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO'. Together they form a unique fingerprint.

  • Cite this